ApprovalTrail

Approval · Notice of Compliance 19768 · 2017

BELBUCA: Notice of Compliance 19768

Issued September 7, 2017

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
19768
Date
September 7, 2017
Company
Purdue PharmaToronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Transfer of drug identification numbers

Products in this notice

BrandDINStatus today
BELBUCA02465221Cancelled Post Market
BELBUCA02465248Cancelled Post Market
BELBUCA02465256Cancelled Post Market
BELBUCA02465264Cancelled Post Market
BELBUCA02465272Cancelled Pre Market
BELBUCA02465280Cancelled Pre Market
BELBUCA02465299Cancelled Pre Market

Medicinal ingredients